FDA.reportPublic FDA data

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Substance profile for UNII 593YOG76RN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Structure render from PubChem CID 516949

Substance Identity#

UNII
593YOG76RN
Preferred term
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Registry number
10049-21-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Na.H2O.H2O4P
Chemical structure for SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Structure render from PubChem CID 516949

Chemical And Database Identifiers#

InChIKey
BBMHARZCALWXSL-UHFFFAOYSA-M
SMILES
O.[Na+].OP(O)([O-])=O
RxCUI
221125
PubChem
516949
NCIt
C61947
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound516949pubchem.ncbi.nlm.nih.gov/compound/516949
PubChem InChIKey SearchBBMHARZCALWXSL-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=BBMHARZCALWXSL-UHFFFAOYSA-M
RxNorm221125mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=221125
NCI ThesaurusC61947ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61947
FDA Substance Registration System593YOG76RNprecision.fda.gov/uniisearch/srs/unii/593YOG76RN

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Flublok ® safely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) Sterile Solution for Intramuscular Injection 2015-2016 Formula Initial U.S. Approval: 20132
INACTIVE INGREDIENT1703aab5-f83a-0d3b-e054-00144ff8d46c1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Flublok ® safely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) Sterile Solution for Intramuscular Injection 2014-2015 Formula Initial U.S. Approval: 20132
INACTIVE INGREDIENTPrinzing Eyewash Station2
ACTIVE INGREDIENT6368bb69-43e9-4304-a30d-03d593c1c05f4
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Flublok ® safely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) Sterile Solution for Intramuscular Injection 2013-2014 Formula Initial U.S. Approval: 20131
INACTIVE INGREDIENTCP2D/AS-3 Blood Collection and Sampling System1
INACTIVE INGREDIENTCP2D/AS-3 Blood Collection and Sampling System1
INACTIVE INGREDIENTCP2D/AS-3 Blood Collection and Sampling System1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Flublok ® safely and effectively. See full prescribing information for Flublok. Flublok (Influenza Vaccine) Sterile Solution for Intramuscular Injection 2012-2013 Formula Initial U.S. Approval: 20131
INACTIVE INGREDIENTThese highlights do not include all the information needed to use PROCRIT safely and effectively. See full prescribing information for PROCRIT. PROCRIT ® (epoetin alfa) injection, for intravenous or subcutaneous use Initial U.S. Approval: 19892
ACTIVE INGREDIENTTriple Blood-Pack™ Unit Anticoagulant Citrate Phosphate Dextrose Adenine Solution (CPDA-1)2
ACTIVE INGREDIENTPHOSPHA 250™ NEUTRAL Supplies 250 mg of phosphorus per tablet2
INACTIVE INGREDIENTI-123 MIBG1
ACTIVE INGREDIENTUnknown Title1
ACTIVE INGREDIENTCP2D/AS-3 Blood Collection and Sampling System3
INACTIVE INGREDIENTdc35ba25-8746-4ed8-83c1-e6b6a10578635
INACTIVE INGREDIENTSperian Eyesaline Eyewash2
INACTIVE INGREDIENTAlclometasone Dipropionate Cream USP, 0.05% Alclometasone Dipropionate Ointment USP, 0.05%1
INACTIVE INGREDIENT82b2fffd-4a1f-4ea3-b156-b8dc51bfde521
INACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTClotrimazole Drug Facts1
ACTIVE INGREDIENTSterile Cord Blood Collection Unit Code 791-083
INACTIVE INGREDIENTNasal Decongestant Drug Facts2
INACTIVE INGREDIENTProchlorperazine Edisylate Injection, USP Rx only3
INACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05%1
INACTIVE INGREDIENTBetamethasone Valerate Cream USP, 0.1%1
INACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05%1
INACTIVE INGREDIENTBuffered Eye-Lert12
ACTIVE INGREDIENT983ce15f-cd37-4f3a-9e51-205860e809763
INACTIVE INGREDIENTCalcitriol Injection Rx Only3
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTMOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)2
INACTIVE INGREDIENTBETAMETHASONE VALERATE CREAM USP, 0.1% BETAMETHASONE VALERATE OINTMENT USP, 0.1% BETAMETHASONE VALERATE LOTION USP, 0.1% (Potency expressed as betamethasone)1
INACTIVE INGREDIENTARANESP (DARBEPOETIN ALFA) INJECTION, SOLUTION ARANESP (DARBEPOETIN ALFA) SOLUTION [AMGEN INC]138
INACTIVE INGREDIENTEPOGEN (EPOETIN ALFA) SOLUTION [AMGEN INC]121
INACTIVE INGREDIENTERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC]34
INACTIVE INGREDIENTROTATEQ (ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT) SOLUTION [MERCK SHARP & DOHME CORP.]27
INACTIVE INGREDIENTTYSABRI (NATALIZUMAB) INJECTION [ELAN PHARMACEUTICALS, INC.]26
INACTIVE INGREDIENTTYSABRI (NATALIZUMAB) INJECTION [BIOGEN IDEC INC. ]22
INACTIVE INGREDIENTAVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]21
INACTIVE INGREDIENTPROCRIT (ERYTHROPOIETIN) INJECTION, SOLUTION [JANSSEN PRODUCTS, LP]21
ACTIVE INGREDIENTOSMOPREP (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC.]20
INACTIVE INGREDIENTSOMAVERT (PEGVISOMANT) KIT [PHARMACIA AND UPJOHN COMPANY]18
INACTIVE INGREDIENTDEFINITY (PERFLUTREN) INJECTION, SUSPENSION [LANTHEUS MEDICAL IMAGING, INC.]17
INACTIVE INGREDIENTFABRAZYME (AGALSIDASE BETA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION]17
INACTIVE INGREDIENTDOXERCALCIFEROL INJECTION, SOLUTION [SANDOZ INC]15
INACTIVE INGREDIENTELAPRASE (IDURSULFASE) SOLUTION, CONCENTRATE [SHIRE US MANUFACTURING INC.]15
INACTIVE INGREDIENTORENCIA (ABATACEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ORENCIA (ABATACEPT) INJECTION, SOLUTION [E.R. SQUIBB & SONS, L.L.C.]15
INACTIVE INGREDIENTZALTRAP (ZIV-AFLIBERCEPT) SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC]14
ACTIVE INGREDIENTCPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]13
INACTIVE INGREDIENTLOTRISONE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE) CREAM [MERCK SHARP & DOHME CORP.]13
INACTIVE INGREDIENTMD-76R (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) SOLUTION [MALLINCKRODT INC.]13
INACTIVE INGREDIENTCHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE) SUSPENSION [CHATTEM, INC.]12
INACTIVE INGREDIENTALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION]11
INACTIVE INGREDIENTBYDUREON (EXENATIDE) INJECTION, SUSPENSION, EXTENDED RELEASE BYDUREON (EXENATIDE) KIT [ASTRAZENECA PHARMACEUTICALS LP]11
ACTIVE INGREDIENTIONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]11
ACTIVE INGREDIENTIONOSOL AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]11
INACTIVE INGREDIENTISTALOL (TIMOLOL MALEATE) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]11
INACTIVE INGREDIENTMENVEO (MENINGOCOCCAL (GROUPS A, C, Y AND W-135) OLIGOSACCHARIDE DIPHTHERIA CRM197 CONJUGATE VACCINE) KIT [NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. ]11
INACTIVE INGREDIENTMYOZYME (ALGLUCOSIDASE ALFA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION]11
ACTIVE INGREDIENTSODIUM PHOSPHATES (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS) INJECTION, SOLUTION [HOSPIRA, INC.]11
INACTIVE INGREDIENTAMPHOTERICIN B INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [X-GEN PHARMACEUTICALS, INC.]10
INACTIVE INGREDIENTELOCON (MOMETASONE FUROATE) LOTION [MERCK SHARP & DOHME CORP.]10
INACTIVE INGREDIENTNAGLAZYME (GALSULFASE) SOLUTION [BIOMARIN PHARMACEUTICAL INC.]10
INACTIVE INGREDIENTABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.]9
ACTIVE INGREDIENTCPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]9
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]9
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]8
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]8
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]8
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]8
INACTIVE INGREDIENTALCLOMETASONE DIPROPIONATE CREAM ALCLOMETASONE DIPROPIONATE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]8
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]8
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]8
INACTIVE INGREDIENTDIPROLENE (BETAMETHASONE DIPROPIONATE) LOTION [MERCK SHARP & DOHME CORP.]8
INACTIVE INGREDIENTLUMIZYME (ALGLUCOSIDASE ALFA) INJECTION, POWDER, FOR SOLUTION [GENZYME CORPORATION]8
INACTIVE INGREDIENTSTRENSIQ (ASFOTASE ALFA) SOLUTION [ALEXION PHARMACEUTICALS INC.]8
INACTIVE INGREDIENTVIMIZIM (ELOSULFASE ALFA) INJECTION, SOLUTION, CONCENTRATE [BIOMARIN PHARMACEUTICAL INC.]8
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
INACTIVE INGREDIENTBETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJECTION, SUSPENSION [AMERICAN REGENT, INC.]7
ACTIVE INGREDIENTCPD/ADSOL RED CELL PRESERVATION SOLUTION SYSTEM (PL 2209) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]7
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION) SOLUTION [FENWAL, INC.]7
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]7
INACTIVE INGREDIENTGONAL-F RFF (FOLLITROPIN ALFA) KIT [EMD SERONO, INC.]7
INACTIVE INGREDIENTHECTOROL (DOXERCALCIFEROL) INJECTION, SOLUTION [GENZYME CORPORATION]7
INACTIVE INGREDIENTIFOSFAMIDE INJECTION [TEVA PARENTERAL MEDICINES, INC.]7
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]6
ACTIVE INGREDIENTANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) BLOOD-PACK UNITS IN PL 146 PLASTIC (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) BLOOD-PACK UNITS IN PL 146 PLASTIC (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTCPD (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTCPDA-1 (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE) SOLUTION [FENWAL, INC.]6
ACTIVE INGREDIENTINTERSOL (PLATELET ADDITIVE 3) SOLUTION [FENWAL, INC.]6
INACTIVE INGREDIENTISOSULFAN BLUE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]6
INACTIVE INGREDIENTMANZANILLA SOPHIA (CHAMOMILE (MATRICARIA CHAMOMILLA L.)) SOLUTION/ DROPS [LABORATORIOS SOPHIA, S.A. DE C.V.]6
ACTIVE INGREDIENTMTL1 LEUCOFLEX (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION WITH AS-1) KIT [MACO PRODUCTIONS]6
INACTIVE INGREDIENTNEUMEGA (OPRELVEKIN) KIT [WYETH BIOPHARMA DIVISION OF WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]6
ACTIVE INGREDIENTVISICOL (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC]6
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]5
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]5
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]5
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]5
ACTIVE INGREDIENTADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]5

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 593YOG76RN page 1 of 1 · 36 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRA-ARTICULAR14 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONINTRA-ARTICULAR13 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRALESIONAL14 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONINTRALESIONAL13 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRAMUSCULAR120 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR1.84 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAMUSCULAR15.55 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONINTRAMUSCULAR13 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR30 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONINTRASYNOVIAL13 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRAVASCULAR0.15 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRAVENOUS120 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS13.61 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS15.55 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SOLUTIONINTRAVENOUS27 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SOLUTIONINTRAVESICAL0.12 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONINTRAVITREAL0.86 %w/v
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONINTRAVITREAL0.04 %w/v
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SOLUTIONOPHTHALMIC4 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SOLUTION/ DROPSOPHTHALMIC8 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SUSPENSIONOPHTHALMIC0.04 %w/w
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215CAPSULEORAL600 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTIONORAL10.06 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SOLUTIONORAL1500 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SUSPENSIONORAL104 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SYRUPORAL20.6 mg/5ml
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215TABLETORAL31.72 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215TABLET, DELAYED RELEASEORAL35 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215TABLET, FILM COATEDORAL0.11 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, SUSPENSIONSOFT TISSUE13 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONSUBCUTANEOUS2 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SUSPENSIONSUBCUTANEOUS0.07 %w/v
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215CREAMTOPICAL10 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215LOTIONTOPICAL8 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215LOTION, AUGMENTEDTOPICAL10 mg
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE593YOG76RN10049215SOLUTIONTOPICAL0.46 %w/v